These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34462790)

  • 1. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
    Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head intra-individual comparison of total-body 2-[
    Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of total-body
    Hu Y; Liu G; Yu H; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
    Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
    J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.
    Masuda Y; Kondo C; Matsuo Y; Uetani M; Kusakabe K
    J Nucl Med; 2009 Jun; 50(6):844-8. PubMed ID: 19443586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose
    He Y; Gu Y; Yu H; Wu B; Wang S; Tan H; Cao Y; Chen S; Sui X; Zhang Y; Shi H
    EJNMMI Phys; 2022 Jul; 9(1):45. PubMed ID: 35802280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
    Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
    Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image quality and lesion detectability in low-dose pediatric
    Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total-body
    Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The image quality, lesion detectability, and acquisition time of
    Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the long axial field-of-view PET/CT with low-dose [
    Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different hydration protocols for the quantification of healthy tissue uptake of half-dose
    Cao Y; Cai D; Sui X; Wang X; Song J; Tan H; Hu P; Zhang Y; Yu H; Shi H
    Quant Imaging Med Surg; 2023 Sep; 13(9):5701-5712. PubMed ID: 37711806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultralow-dose [
    Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
    Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.